Newsletter Signup | Join Community
The checkpoint inhibitor Tecentiq (atezolizumab) improves the outcomes of treatment for bladder cancer.
FDA deems enfortumab vedotin promising for bladder cancer already treated with checkpoint inhibitors-ASCO update
Dr. Michael O’Donnell, MD, Director of Urologic Oncology University of Iowa answers questions about bladder cancer.
Everywhere we look in the media, we find claims that different diets can improve our quality of life.
Stay Current With Bladder Cancer Treatment Advances & Connect with Others
FDA Approves PD-1 Checkpoint Inhibitor Opdivo for Treatment of Bladder Cancer
Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer
IDO inhibitor epacadostat and the anti-PD-1 drug Keytruda (pembrolizumab) promising in bladder cancer.
Can anyone share the experience with Keytruda? Any side effects?